Kaposi’s Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

CRISPR activation (CRISPRa) has revealed great potential as a tool to modulate the expression of targeted cellular genes. Here, we successfully applied the CRISPRa system to trigger the Kaposi’s sarcoma-associated herpesvirus (KSHV) reactivation in latently infected cells by selectively activating ORF50 gene directly from the virus genome. We found that a nuclease-deficient Cas9 (dCas9) fused to a destabilization domain (DD) and 12 copies of the VP16 activation domain (VP192) triggered a more efficient KSHV lytic cycle and virus production when guided to two different sites on the ORF50 promoter, instead of only a single site. To our surprise, the virus reactivation induced by binding of the stable DD-dCas9-VP192 on the ORF50 promoter was even more efficient than reactivation induced by ectopic expression of ORF50. This suggests that recruitment of additional transcriptional activators to the ORF50 promoter, in addition to ORF50 itself, are needed for the efficient virus production. Further, we show that CRISPRa can be applied to selectively express the early lytic gene, ORF57, without disturbing the viral latency. Therefore, CRISPRa-based systems can be utilized to facilitate virus–host interaction studies by controlling the expression of not only cellular but also of specific KSHV genes.

References Powered by Scopus

STAR: Ultrafast universal RNA-seq aligner

29833Citations
N/AReaders
Get full text

FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features

15135Citations
N/AReaders
Get full text

Fastp: An ultra-fast all-in-one FASTQ preprocessor

13791Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Crispr-mediated gene activation (Crispra) of pp38/pp24 orchestrates events triggering lytic infection in marek’s disease virus-transformed cell lines

6Citations
N/AReaders
Get full text

Current Approaches to Epigenetic Therapy

5Citations
N/AReaders
Get full text

Crispr interference efficiently silences latent and lytic viral genes in kaposi’s sarcoma-associated herpesvirus-infected cells

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Elbasani, E., Falasco, F., Gramolelli, S., Nurminen, V., Günther, T., Weltner, J., … Ojala, P. M. (2020). Kaposi’s Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter. Viruses, 12(9). https://doi.org/10.3390/v12090952

Readers over time

‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

71%

Professor / Associate Prof. 1

14%

Researcher 1

14%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

50%

Agricultural and Biological Sciences 2

25%

Immunology and Microbiology 2

25%

Save time finding and organizing research with Mendeley

Sign up for free
0